Novan Inc

NASDAQ:NOVN   1:51:53 PM EDT
8.34
-0.25 (-2.91%)
Products, Other Pre-Announcement

Novan Announces Strategic Priorities And Outlines Key Milestones

Published: 09/09/2021 12:16 GMT
Novan Inc (NOVN) - Novan Announces Strategic Priorities and Outlines Key Milestones.
Novan Inc - Planning for Three Potential New Drug Application (nda) Filings in Three Years.
Novan Inc - First NDA Submission Expected in Q3 2022 for Lead Program Sb206 in Molluscum Contagiosum.
Novan Inc - Sb019 Sars-cov-2 Development Program Advancing Toward Phase 1 Study in Healthy Volunteers, Targeted for 1h 2022.